ArticleMarine drugs2017

FUSION-Guided Hypothesis Development Leads to the Identification of N⁶,N⁶-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor.

Rachel M Vaden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.